Fibrosis is when scar tissue forms in your body. This happens when an injury or inflammation causes your body to make too much scar tissue. This scar tissue can make organs stiff and less able to function properly. It can happen in many different parts of the body.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Fibrosis is the buildup of scar tissue inside an organ. When tissue is injured or inflamed over and over, the body's repair process lays down tough, fibrous connective tissue in place of normal working tissue. Some scarring is part of ordinary healing, but when it keeps accumulating, the organ becomes stiffer and does its job less well. Fibrosis is a process rather than a single disease, and it can affect almost any organ, including the liver, lungs, kidneys, heart and skin. What it means for a person depends on where it happens and what is driving it. The two forms people most often encounter are liver fibrosis, whose most advanced stage is called cirrhosis, and pulmonary fibrosis, scarring deep in the lungs that makes it harder to breathe and to get oxygen into the blood. Cystic fibrosis, despite its name, is a separate inherited disease of the mucus and sweat glands. Early fibrosis often causes no symptoms at all. Many people with liver scarring feel well until the damage is advanced, while lung fibrosis typically shows up as shortness of breath on exertion and a dry cough that does not go away.
Fibrosis usually follows long-lasting injury or inflammation rather than a single event. The cause matters because it is usually the main thing treatment can change. In the liver, the most common causes in the United States are heavy alcohol use, fat buildup in the liver linked to overweight, obesity, metabolic syndrome or type 2 diabetes, and long-term hepatitis B or hepatitis C infection. Less common causes include autoimmune hepatitis, diseases that damage the bile ducts, inherited conditions such as hemochromatosis and Wilson disease, long-term use of certain medicines, and chronic heart failure that slows blood flow out of the liver. Some people have more than one cause. In the lungs, scarring can follow exposure to environmental pollutants, some medicines, or autoimmune connective tissue diseases such as systemic sclerosis. In most cases no cause is found, which is called idiopathic pulmonary fibrosis (IPF). IPF is most often diagnosed in people in their 60s and 70s, and it is more common in men, in people who have smoked, and in people with a parent or sibling who has it. Inherited genes also influence how much scarring a given injury produces, which helps explain why two people with the same exposure can fare very differently.
Because fibrosis is a change in tissue rather than a symptom, it is usually found while investigating a particular organ. The assessment asks two questions: how much scarring there is, and what is causing it. For the liver, blood tests check liver enzymes, bilirubin (a yellow pigment the liver clears), albumin (a protein the liver makes) and blood counts, and look for hepatitis B or C and autoimmune liver disease. Ultrasound, CT or MRI shows the liver's size, shape and texture. Elastography is a painless imaging test that measures how stiff the liver is: the stiffer the liver, the more scarring is likely, and repeat measurements can show whether it is improving or worsening. A liver biopsy, in which a needle removes a small sample of tissue, is used when other results are unclear or the cause is uncertain. For the lungs, a high-resolution chest CT scan is the central test, and in IPF it often shows a characteristic honeycomb-like pattern. Lung function tests, which are breathing tests, measure how much air the lungs can hold and whether oxygen levels are low; they show how severe the disease is and are repeated to track change over time. Blood tests look for autoimmune disease, and a lung biopsy is sometimes needed. IPF is diagnosed only after other causes of lung scarring have been ruled out.
Treatment has two aims: stop or control what is causing the scarring, and manage the effects of scarring that is already there. Fibrosis was long considered permanent, but research shows it is a more dynamic process than once thought, and in some situations, especially in the liver, scarring can stabilize or partly improve once the injury stops. Heavily scarred tissue, as in advanced cirrhosis, generally does not return to normal. For liver fibrosis, treating the cause is the most effective step. That means stopping alcohol completely when alcohol is involved, and losing weight when fatty liver disease is the cause, which can reduce liver fat, inflammation and scarring. Antiviral medicines cure more than 95% of people with chronic hepatitis C in 8 to 12 weeks, and hepatitis B antivirals slow or stop further damage. For adults with metabolic dysfunction-associated steatohepatitis (MASH, an inflamed form of fatty liver disease formerly called NASH) who have moderate to advanced fibrosis but not cirrhosis, two prescription medicines are approved alongside diet and exercise: resmetirom (Rezdiffra), a daily tablet that acts on thyroid hormone receptors in the liver, and semaglutide (Wegovy), a weekly injection that acts like the gut hormone glucagon-like peptide-1 and is also used for weight loss. Both received accelerated approval based on improvements seen in liver tissue, and studies are still confirming whether they prevent cirrhosis and its complications. For pulmonary fibrosis, antifibrotic medicines slow the loss of lung function rather than restore what has been lost. Nintedanib (Ofev) and pirfenidone (Esbriet, also available as a generic) are approved for IPF, and nintedanib is also used for other progressive lung scarring, including scarring linked to systemic sclerosis. Nerandomilast (Jascayd), approved in 2025, is a newer option for IPF and progressive pulmonary fibrosis. Stomach and bowel side effects, especially diarrhea and nausea, are common with these medicines, and regular liver blood tests are part of treatment. Oxygen therapy eases breathlessness and makes activity easier, and pulmonary rehabilitation, a supervised program of exercise training and education, builds stamina. When an organ is failing despite treatment, transplantation may be considered: a liver transplant for liver failure from cirrhosis, or a lung transplant for some people with severe pulmonary fibrosis.
The course depends heavily on the organ and the cause. Liver fibrosis often progresses quietly over years, and many people learn about it only from a routine blood test or scan. When the cause is removed early, the liver can remain stable for a long time. Once cirrhosis develops, care shifts toward preventing complications. Scarring slows blood flow through the liver and raises pressure in the portal vein, the large vein that carries blood from the intestines to the liver; this can cause fluid buildup in the belly, swelling in the legs and enlarged veins called varices that can bleed. Doctors often prescribe medicines to lower that pressure and check for liver cancer with an ultrasound, often every 6 months, because finding it early improves the chance of cure. Day to day, protecting the liver means avoiding alcohol, checking with a clinician before taking pain relievers such as acetaminophen or ibuprofen, sleep aids or supplements, and staying up to date on vaccines, including those for hepatitis A and B. Pulmonary fibrosis, particularly IPF, usually worsens over time, but the pace varies widely and cannot be predicted for an individual; some people stay stable for long periods. Lung function tests every few months show how things are going. Many people eventually need oxygen, at first with exercise and later more of the time. Staying physically active, avoiding smoke, dust and poor air quality, and getting support for the anxiety and low mood that often accompany a serious lung condition all make a difference. As breathing becomes more limited, it helps to talk early about transplant eligibility, palliative care focused on comfort and quality of life, and advance care planning.
Arrange a medical visit if you have risk factors for liver disease, such as heavy drinking, obesity, type 2 diabetes or hepatitis, or if a blood test has shown abnormal liver results. The same applies to shortness of breath during everyday activity or a dry cough that has lasted for weeks. If you have pulmonary fibrosis, contact your care team right away if breathing becomes harder, faster or shallower, you need to lean forward to breathe comfortably, your fingertips or nail beds look blue, you cough up dark mucus, or your symptoms worsen over a few days or weeks, since a sudden flare can be serious. If you have cirrhosis, get emergency care for vomiting blood, black or bloody stools, new or worsening confusion or drowsiness, a fever, belly swelling or pain that is new or suddenly worse, or yellowing of the skin or eyes that appears or deepens quickly.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Fibrosis is like, what's helped you, or ask the community a question.